Andrew S Boyer Amneal Pharmaceuticals, Inc. (AMRX) insider trading activity

Andrew S Boyer is Executive Vice President of Amneal Pharmaceuticals, Inc.. Currently has a direct ownership of 256,670 shares of AMRX, which is worth approximately $2.1 Million. The most recent transaction as insider was on Aug 15, 2024, when has been sold 40,225 shares (Class A Common Stock) at a price of $7.85 per share, resulting in proceeds of $315,766. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 257K

19.64% 3M change

4.87% 12M change

Total Value Held $2.1 Million

ANDREW S BOYER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 15 2024	SELL Open market or private sale	$315,766 $7.85 p/Share	40,225 Reduced 13.55%	256,670 Class A Common Stock
Aug 14 2024	SELL Open market or private sale	$175,615 $7.81 p/Share	22,486 Reduced 7.04%	296,895 Class A Common Stock
Mar 03 2024	SELL Payment of exercise price or tax liability	$243,754 $5.47 p/Share	44,562 Reduced 12.24%	319,381 Class A Common Stock
Mar 03 2024	BUY Exercise of conversion of derivative security	-	88,945 Added 20.53%	344,278 Class A Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$88,717 $5.47 p/Share	16,219 Reduced 5.57%	274,998 Class A Common Stock
Mar 01 2024	BUY Exercise of conversion of derivative security	-	31,371 Added 9.72%	291,217 Class A Common Stock
Feb 27 2024	SELL Payment of exercise price or tax liability	$94,534 $5.71 p/Share	16,556 Reduced 5.99%	259,846 Class A Common Stock
Feb 27 2024	BUY Exercise of conversion of derivative security	-	31,663 Added 10.28%	276,402 Class A Common Stock
Aug 11 2023	SELL Open market or private sale	$121,017 $4.13 p/Share	29,302 Reduced 10.69%	244,739 Class A Common Stock
Jun 30 2023	SELL Payment of exercise price or tax liability	$35,870 $3.1 p/Share	11,571 Reduced 4.05%	274,041 Class A Common Stock
Jun 30 2023	BUY Exercise of conversion of derivative security	-	23,095 Added 7.48%	285,612 Class A Common Stock
Mar 03 2023	SELL Payment of exercise price or tax liability	$37,795 $1.92 p/Share	19,685 Reduced 6.98%	262,517 Class A Common Stock
Mar 03 2023	BUY Exercise of conversion of derivative security	-	39,251 Added 12.21%	282,202 Class A Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$48,001 $2.09 p/Share	22,967 Reduced 8.64%	242,951 Class A Common Stock
Mar 01 2023	BUY Exercise of conversion of derivative security	-	43,717 Added 14.44%	259,072 Class A Common Stock
Feb 27 2023	SELL Payment of exercise price or tax liability	$37,923 $2.16 p/Share	17,557 Reduced 7.32%	222,201 Class A Common Stock
Feb 27 2023	BUY Exercise of conversion of derivative security	-	31,662 Added 11.67%	239,758 Class A Common Stock
Jun 30 2022	SELL Payment of exercise price or tax liability	$36,831 $3.18 p/Share	11,582 Reduced 5.27%	208,096 Class A Common Stock
Jun 30 2022	BUY Exercise of conversion of derivative security	-	23,094 Added 9.51%	219,678 Class A Common Stock
May 07 2022	SELL Payment of exercise price or tax liability	$28,400 $3.4 p/Share	8,353 Reduced 4.08%	196,584 Class A Common Stock
May 07 2022	BUY Exercise of conversion of derivative security	-	16,656 Added 7.52%	204,937 Class A Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$97,566 $4.45 p/Share	21,925 Reduced 10.43%	188,281 Class A Common Stock
Mar 01 2022	BUY Exercise of conversion of derivative security	-	43,716 Added 17.65%	204,014 Class A Common Stock
Feb 27 2022	SELL Payment of exercise price or tax liability	$75,432 $4.59 p/Share	16,434 Reduced 8.98%	166,490 Class A Common Stock
Feb 27 2022	BUY Exercise of conversion of derivative security	-	31,662 Added 14.75%	182,924 Class A Common Stock

ASB

Andrew S Boyer

Executive Vice President

Bridgewater, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMRX shares.

Notify only if

Value

Insider Trading

Get notified when an Amneal Pharmaceuticals, Inc. insider buys or sells AMRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Amneal Pharmaceuticals, Inc.

Track Activities on AMRX

Account